Healthcare Triangle Reports 158% Revenue Growth to $9.19 Million, Net Loss Increases to $4.39 Million

Healthcare Triangle, Inc. reported significant financial growth in its latest quarterly filing, with revenues reaching $9.19 million for the three months ended June 30, 2026, compared to $3.56 million in the same period last year, marking a 158% increase. The company attributed this growth primarily to its newly acquired Customer Engagement Services segment, which generated $6.31 million in revenue, a substantial increase from zero in the previous year. However, revenue from Software Services and Managed Services and Support segments saw declines, with Software Services dropping to $1.55 million from $2.14 million and Managed Services decreasing to $1.27 million from $1.34 million.

The company's operating expenses also rose significantly, with general and administrative costs increasing by 308% to $4.82 million, driven by the integration of the Teyame and Datono acquisitions. Overall, Healthcare Triangle reported a net loss of $4.39 million for the quarter, compared to a loss of $1.37 million in the prior year. The increase in losses was attributed to higher operational costs and interest expenses, which rose to $0.09 million from $0.02 million year-over-year.

In terms of strategic developments, Healthcare Triangle completed the acquisition of Teyame 360 S.L. and Datono Mediacion S.L. on January 1, 2026, for a total consideration of up to $50 million. This acquisition is expected to enhance the company's capabilities in artificial intelligence-driven healthcare technologies and improve its customer engagement offerings. The integration of Teyame's operations is seen as a critical factor for future growth, with the company aiming to leverage cross-selling opportunities between its existing customer base and the new services acquired.

Operationally, the company reported a total of 40 full-time employees and 27 subcontractors as of June 30, 2026. The current ratio decreased to 0.6 from 1.03 at the end of 2025, indicating a tighter liquidity position. Cash and cash equivalents stood at $1.91 million, down from $3.23 million a year earlier. Despite the losses, management expressed confidence in the company's ability to fund operations and meet obligations for at least the next 12 months, bolstered by access to an equity line of credit and ongoing financing activities.

Looking ahead, Healthcare Triangle anticipates continued growth driven by its expanded service offerings and the integration of AI capabilities into its healthcare technology solutions. The company plans to invest in sales and marketing to promote its solutions and expects to see improvements in gross margins as new contracts are negotiated at higher rates. However, the company also acknowledged the challenges of maintaining customer retention and expanding its market share in a competitive landscape.